The COP:TRIN vision
Chronic obstructive pulmonary disease (COPD) is a frequent condition worldwide that impairs breathing, causes coughing and mucus hyper secretion. In Denmark, the prevalence of COPD has been estimated at 430,000, of whom 40,000 have severe to very severe disease.
Our vision is to establish a nationwide respiratory medicine research collaboration consisting of highly skilled entities within biomarkers, genetics and clinical trials. The aim is to perform urgently needed pathophysiological, genetic and clinical trials in an academic and independent research environment, building on strengths in Danish clinical research as well as biomarker technology.
Headline: A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol
Media: BMC Pulmonary Medicine
Read Article here
Nyt forskningsstudie kigger på individuel behandling af KOL-patienter